134 related articles for article (PubMed ID: 31079681)
1. Concise chemoenzymatic synthesis of heparan sulfate analogues as potent BACE-1 inhibitors.
Li J; Li J; Sun T; Cai C; Shao M; Yu G
Carbohydr Polym; 2019 Aug; 217():232-239. PubMed ID: 31079681
[TBL] [Abstract][Full Text] [Related]
2. Heparin derivatives as inhibitors of BACE-1, the Alzheimer's beta-secretase, with reduced activity against factor Xa and other proteases.
Patey SJ; Edwards EA; Yates EA; Turnbull JE
J Med Chem; 2006 Oct; 49(20):6129-32. PubMed ID: 17004727
[TBL] [Abstract][Full Text] [Related]
3. Single-entity heparan sulfate glycomimetic clusters for therapeutic applications.
Tyler PC; Guimond SE; Turnbull JE; Zubkova OV
Angew Chem Int Ed Engl; 2015 Feb; 54(9):2718-23. PubMed ID: 25640820
[TBL] [Abstract][Full Text] [Related]
4. Novel heparan sulphate analogues: inhibition of beta-secretase cleavage of amyloid precursor protein.
Patey SJ; Yates EA; Turnbull JE
Biochem Soc Trans; 2005 Nov; 33(Pt 5):1116-8. PubMed ID: 16246059
[TBL] [Abstract][Full Text] [Related]
5. Heparan sulfate regulates amyloid precursor protein processing by BACE1, the Alzheimer's beta-secretase.
Scholefield Z; Yates EA; Wayne G; Amour A; McDowell W; Turnbull JE
J Cell Biol; 2003 Oct; 163(1):97-107. PubMed ID: 14530380
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of a targeted library of heparan sulfate hexa- to dodecasaccharides as inhibitors of β-secretase: potential therapeutics for Alzheimer's disease.
Schwörer R; Zubkova OV; Turnbull JE; Tyler PC
Chemistry; 2013 May; 19(21):6817-23. PubMed ID: 23553710
[TBL] [Abstract][Full Text] [Related]
7. Low anticoagulant heparin oligosaccharides as inhibitors of BACE-1, the Alzheimer's β-secretase.
Zhang X; Zhao X; Lang Y; Li Q; Liu X; Cai C; Hao J; Li G; Yu G
Carbohydr Polym; 2016 Oct; 151():51-59. PubMed ID: 27474542
[TBL] [Abstract][Full Text] [Related]
8. Directing the biological activities of heparan sulfate oligosaccharides using a chemoenzymatic approach.
Xu Y; Wang Z; Liu R; Bridges AS; Huang X; Liu J
Glycobiology; 2012 Jan; 22(1):96-106. PubMed ID: 21835782
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of BACE-1 inhibitors utilizing a tertiary hydroxyl motif as the transition state mimic.
Wångsell F; Russo F; Sävmarker J; Rosenquist A; Samuelsson B; Larhed M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4711-4. PubMed ID: 19576765
[TBL] [Abstract][Full Text] [Related]
10. Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leads.
Huang Y; Strobel ED; Ho CY; Reynolds CH; Conway KA; Piesvaux JA; Brenneman DE; Yohrling GJ; Moore Arnold H; Rosenthal D; Alexander RS; Tounge BA; Mercken M; Vandermeeren M; Parker MH; Reitz AB; Baxter EW
Bioorg Med Chem Lett; 2010 May; 20(10):3158-60. PubMed ID: 20399652
[TBL] [Abstract][Full Text] [Related]
11. 3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: Potent and permeable BACE-1 inhibitors.
Peschiulli A; Oehlrich D; Rombouts F; Vos A; Gijsen HJ
Bioorg Med Chem Lett; 2020 Apr; 30(8):126999. PubMed ID: 32089426
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and SAR of potent statine-based BACE-1 inhibitors: exploration of P1 phenoxy and benzyloxy residues.
Bäck M; Nyhlén J; Kvarnström I; Appelgren S; Borkakoti N; Jansson K; Lindberg J; Nyström S; Hallberg A; Rosenquist S; Samuelsson B
Bioorg Med Chem; 2008 Nov; 16(21):9471-86. PubMed ID: 18842420
[TBL] [Abstract][Full Text] [Related]
13. Investigation of α-phenylnorstatine and α-benzylnorstatine as transition state isostere motifs in the search for new BACE-1 inhibitors.
Wångsell F; Nordeman P; Sävmarker J; Emanuelsson R; Jansson K; Lindberg J; Rosenquist S; Samuelsson B; Larhed M
Bioorg Med Chem; 2011 Jan; 19(1):145-55. PubMed ID: 21183353
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, and SAR of macrocyclic tertiary carbinamine BACE-1 inhibitors.
Lindsley SR; Moore KP; Rajapakse HA; Selnick HG; Young MB; Zhu H; Munshi S; Kuo L; McGaughey GB; Colussi D; Crouthamel MC; Lai MT; Pietrak B; Price EA; Sankaranarayanan S; Simon AJ; Seabrook GR; Hazuda DJ; Pudvah NT; Hochman JH; Graham SL; Vacca JP; Nantermet PG
Bioorg Med Chem Lett; 2007 Jul; 17(14):4057-61. PubMed ID: 17482814
[TBL] [Abstract][Full Text] [Related]
15. The role of heparan sulfate in the generation of Abeta.
Patey SJ
Drug News Perspect; 2006 Sep; 19(7):411-6. PubMed ID: 17080204
[TBL] [Abstract][Full Text] [Related]
16. Production methods for heparosan, a precursor of heparin and heparan sulfate.
Chavaroche AA; van den Broek LA; Eggink G
Carbohydr Polym; 2013 Mar; 93(1):38-47. PubMed ID: 23465899
[TBL] [Abstract][Full Text] [Related]
17. Flavonols and flavones as BACE-1 inhibitors: structure-activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features.
Shimmyo Y; Kihara T; Akaike A; Niidome T; Sugimoto H
Biochim Biophys Acta; 2008 May; 1780(5):819-25. PubMed ID: 18295609
[TBL] [Abstract][Full Text] [Related]
18. Design and synthesis of 2,3,5-substituted imidazolidin-4-one inhibitors of BACE-1.
Barrow JC; Rittle KE; Ngo PL; Selnick HG; Graham SL; Pitzenberger SM; McGaughey GB; Colussi D; Lai MT; Huang Q; Tugusheva K; Espeseth AS; Simon AJ; Munshi SK; Vacca JP
ChemMedChem; 2007 Jul; 2(7):995-9. PubMed ID: 17458843
[No Abstract] [Full Text] [Related]
19. Human beta-secretase (BACE) and BACE inhibitors.
John V; Beck JP; Bienkowski MJ; Sinha S; Heinrikson RL
J Med Chem; 2003 Oct; 46(22):4625-30. PubMed ID: 14561080
[No Abstract] [Full Text] [Related]
20. Structure-based design and synthesis of macroheterocyclic peptidomimetic inhibitors of the aspartic protease beta-site amyloid precursor protein cleaving enzyme (BACE).
Hanessian S; Yang G; Rondeau JM; Neumann U; Betschart C; Tintelnot-Blomley M
J Med Chem; 2006 Jul; 49(15):4544-67. PubMed ID: 16854060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
